BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to PLC/PRF/5 cell line is 26
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | PLC/PRF/5 | NA | FACs followed by Western Blotting and SFA | NA | 0.4 | 0.7582 | 22773665 |
| PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | PLC/PRF/5 | NA | SP assay followed by FACs and SFA | NA | 0.4 | 0.7582 | 25997710 |
| PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | PLC/PRF/5 | NA | FACs | NA | 0.4 | 0.7582 | 21879266 |
| PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | PLC/PRF/5 | NA | SP assay followed by FACs | NA | 0.4 | 0.7582 | 25997710 |
| MYC | 7553 | LTM | Hepatic Cancer | Carcinoma | PLC/PRF/5 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.1304 | 27312708 |
| NANOG | 20857 | LTM | Hepatic Cancer | Carcinoma | PLC/PRF/5 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.5461 | 27312708 |
| POU5F1 | 9221 | LTM | Hepatic Cancer | Carcinoma | PLC/PRF/5 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.6448 | 27312708 |
| POU5F1 | 9221 | LTM | Hepatic Cancer | Carcinoma | PLC/PRF/5 | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.6448 | 22773665 |
| SIRT1 | 14929 | LTM | Hepatic Cancer | Carcinoma | PLC/PRF/5 | NA | Western Blotting followed by SFA | NA | 0.28 | 0.0021 | 27312708 |
| SOX2 | 11195 | LTM | Hepatic Cancer | Carcinoma | PLC/PRF/5 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.5695 | 27312708 |
| BMI1 | 1066 | LTM | Hepatic Cancer | Carcinoma | PLC/PRF/5 | NA | SP assay followed by IHC staining | NA | 0.24 | 0.1135 | 18829528 |
| BMI1 | 1066 | LTM | Hepatic Cancer | Carcinoma | PLC/PRF/5 | NA | SFA followed by qRT-PCR | NA | 0.24 | 0.1135 | 22773665 |
| ABCG2 | 74 | LTM | Hepatic Cancer | Carcinoma | PLC/PRF/5 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.1739 | 22773665 |
| ABCG2 | 74 | LTM | Hepatic Cancer | Carcinoma | PLC/PRF/5 | NA | SP assay followed by FACs and SFA | NA | 0.2 | 0.1739 | 25997710 |
| ABCG2 | 74 | LTM | Hepatic Cancer | Carcinoma | PLC/PRF/5 | NA | SP assay followed by FACs | NA | 0.2 | 0.1739 | 25997710 |
| CTNNB1 | 2514 | LTM | Hepatic Cancer | Carcinoma | PLC/PRF/5 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0647 | 22773665 |
| ANPEP | 500 | LTM | Hepatic Cancer | Carcinoma | PLC/PRF/5 | NA | FACs | NA | 0.12 | 0.0117 | 21879266 |
| ANPEP | 500 | LTM | Hepatic Cancer | Carcinoma | PLC/PRF/5 | NA | SP assay followed by FACs and SFA | NA | 0.12 | 0.0117 | 20697159 |
| CD44 | 1681 | LTM | Hepatic Cancer | Carcinoma | PLC/PRF/5 | NA | SP assay followed by FACs and SFA | NA | 0.12 | 1 | 25997710 |
| CD44 | 1681 | LTM | Hepatic Cancer | Carcinoma | PLC/PRF/5 | NA | SP assay followed by FACs | NA | 0.12 | 1 | 25997710 |
| EPCAM | 11529 | LTM | Hepatic Cancer | Carcinoma | PLC/PRF/5 | NA | SP assay followed by FACs and SFA | NA | 0.12 | 0.211 | 25997710 |
| EPCAM | 11529 | LTM | Hepatic Cancer | Carcinoma | PLC/PRF/5 | NA | SP assay followed by FACs | NA | 0.12 | 0.211 | 25997710 |
| THY1 | 11801 | LTM | Hepatic Cancer | Carcinoma | PLC/PRF/5 | NA | SP assay followed by FACs and SFA | NA | 0.12 | 0.0371 | 25997710 |
| THY1 | 11801 | LTM | Hepatic Cancer | Carcinoma | PLC/PRF/5 | NA | FACs | NA | 0.12 | 0.0371 | 21879266 |
| THY1 | 11801 | LTM | Hepatic Cancer | Carcinoma | PLC/PRF/5 | NA | SP assay followed by FACs | NA | 0.12 | 0.0371 | 20697159 |
| THY1 | 11801 | LTM | Hepatic Cancer | Carcinoma | PLC/PRF/5 | NA | SP assay followed by FACs | NA | 0.12 | 0.0371 | 25997710 |